118 related articles for article (PubMed ID: 10644281)
21. Update in endocrinology.
Whitcomb RW
Ann Intern Med; 1998 May; 128(10):871. PubMed ID: 9599203
[No Abstract] [Full Text] [Related]
22. [Medication of the month. Rosiglitazone (Avandia)].
Scheen AJ
Rev Med Liege; 2002 Apr; 57(4):236-9. PubMed ID: 12073798
[TBL] [Abstract][Full Text] [Related]
23. Rosiglitazone--useful drug but has side effects.
Vidhya S; Mohan V
J Assoc Physicians India; 2002 Apr; 50():615. PubMed ID: 12164432
[No Abstract] [Full Text] [Related]
24. Hepatocellular injury in a patient receiving rosiglitazone. A case report.
Al-Salman J; Arjomand H; Kemp DG; Mittal M
Ann Intern Med; 2000 Jan; 132(2):121-4. PubMed ID: 10644273
[TBL] [Abstract][Full Text] [Related]
25. Thiazolidinediones and liver toxicity.
Scheen AJ
Diabetes Metab; 2001 Jun; 27(3):305-13. PubMed ID: 11431595
[TBL] [Abstract][Full Text] [Related]
26. Hepatotoxicity with thiazolidinediones: is it a class effect?
Scheen AJ
Drug Saf; 2001; 24(12):873-88. PubMed ID: 11735645
[TBL] [Abstract][Full Text] [Related]
27. Accelerated hypertension due to rosiglitazone therapy.
Vikram NK; Misra A; Devi JR
Indian Heart J; 2002; 54(6):733. PubMed ID: 12674195
[No Abstract] [Full Text] [Related]
28. Rosiglitazone maleate. Ketotifen fumarate.
Am J Health Syst Pharm; 1999 Oct; 56(19):1924-6. PubMed ID: 10554908
[No Abstract] [Full Text] [Related]
29. Advisory panel hears contradictory evidence, backs keeping troglitazone on market.
Miller JL
Am J Health Syst Pharm; 1999 May; 56(9):840, 842. PubMed ID: 10344603
[No Abstract] [Full Text] [Related]
30. Thiazolidinediones for type 2 diabetes. New agents reduce insulin resistance but need long term clinical trials.
Krentz AJ; Bailey CJ; Melander A
BMJ; 2000 Jul; 321(7256):252-3. PubMed ID: 10915108
[No Abstract] [Full Text] [Related]
31. Troglitazone-associated hepatic failure.
Misbin RI
Ann Intern Med; 1999 Feb; 130(4 Pt 1):330. PubMed ID: 10068399
[No Abstract] [Full Text] [Related]
32. Lessons from the glitazones: a story of drug development.
Gale EA
Lancet; 2001 Jun; 357(9271):1870-5. PubMed ID: 11410214
[TBL] [Abstract][Full Text] [Related]
33. [Rosiglitazone: clinical data].
Blickle JF
Ann Endocrinol (Paris); 2002 Apr; 63(2 Pt 2):1S27-33. PubMed ID: 12037505
[No Abstract] [Full Text] [Related]
34. Pioglitazone and rosiglitazone for diabetes.
Drug Ther Bull; 2001 Sep; 39(9):65-8. PubMed ID: 11586802
[TBL] [Abstract][Full Text] [Related]
35. Thiazolidinedione-associated congestive heart failure and pulmonary edema.
Kermani A; Garg A
Mayo Clin Proc; 2003 Sep; 78(9):1088-91. PubMed ID: 12962163
[TBL] [Abstract][Full Text] [Related]
36. Liver failure in a patient receiving rosiglitazone therapy.
Su DH; Lai MY; Wu HP
Diabet Med; 2006 Jan; 23(1):105-6. PubMed ID: 16409577
[No Abstract] [Full Text] [Related]
37. Thiazolidinediones for type 2 diabetes. All glitazones may exacerbate heart failure.
Benbow A; Stewart M; Yeoman G
BMJ; 2001 Jan; 322(7280):236. PubMed ID: 11159623
[No Abstract] [Full Text] [Related]
38. Diabetes medicine update. Old dogs, new tricks.
Nakamoto M
Diabetes Self Manag; 2003; 20(1):14-5. PubMed ID: 12632553
[No Abstract] [Full Text] [Related]
39. Case series of liver failure associated with rosiglitazone and pioglitazone.
Floyd JS; Barbehenn E; Lurie P; Wolfe SM
Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1238-43. PubMed ID: 19623674
[TBL] [Abstract][Full Text] [Related]
40. Rapid-onset subfulminant liver failure associated with troglitazone.
Jagannath S; Rai R
Ann Intern Med; 2000 Apr; 132(8):677. PubMed ID: 10766693
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
